Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT03074825 · TERMINATED
Trial details
- NCT number
- NCT03074825
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2017-08-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.